| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Lipman Andrew D serves as a Director at NUS. Across recent SEC filings that breaks down to 0 buys and 31 sells. Those positions are worth an estimated $113K at current prices.
Historically, Lipman Andrew D's trades have earned a strong insider score of 85/100 across 30 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +48.1%.
The biggest single holding is NUS (~$113K) as Director. The recent filings there lean toward selling, a net 89,400 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2016 | NUS Nu Skin Enterprises, Inc. | Director | Sell | 30,000 | $64.13 | $1,923,900.00 | -45.4% |